Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2003

View Archived Issues

Novel inhibitors of MMP-12 and other metalloproteinases identified at AstraZeneca

Asahi Kasei presents new beta3-adrenoceptor agonists in recent patent

Imidazolinone-based p38 kinase inhibitors in early development at Tanabe Seiyaku

Shionogi describes novel NR1/NR2B-selective NMDA antagonists

Novel antiobesity agents in Bayer development pipeline

New analgesic COX-1 inhibitors prepared and tested by Fujisawa team

Novel MMP, TACE and/or aggrecanase inhibitors and their use reported by BMS scientists

Dual alpha4beta1/alpha4beta7 integrin antagonist profiled at ATS meeting

Potential new asthma therapeutic acts by neutralizing IL-13

Vaccine for specifically neutralizing IL-13 for use in asthma developed at GSK

SD-208 inhibits lung fibrosis induced by TGF-beta1 overexpression in rats

Inhibition of lung inflammation reported for the macrolide Z-104657A in rats

TAS-203 more effective than cilomilast in airways inflammation

Merck discontinues development of two diabetes projects

Launch of Clarinex RediTabs

Multiferon use expanded in Mexico

PTI-901 significantly improves common symptoms of IBS

Phase II efficacy data reported for intranasal apomorphine in FSD

No evidence of carcinogenicity in NexACT rat study

New phase II trial evaluates ISIS-14803 in HCV

Enrollment under way in pivotal Pompe's disease study of Myozyme

Microbially produced antiplatelet agent identified by Japanese group

Estrone derivatives with potent inhibitory activity against steroid sulfatase

IL-9-neutralizing antibody effective in mouse model of asthma

Allos plans NDA submission for RSR-13 for brain metastases from breast cancer

New phase II trial of Triapine and gemcitabine in pancreatic cancer

NCX-4016 does not negatively interact with COX-2 inhibitor in the stomach

Echelon receives NIH grant to further cancer research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...